These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35569552)

  • 1. Dihydroartemisinin inhibits the growth of pancreatic cells by inducing ferroptosis and activating antitumor immunity.
    Zhang H; Zhuo Y; Li D; Zhang L; Gao Q; Yang L; Yuan X
    Eur J Pharmacol; 2022 Jul; 926():175028. PubMed ID: 35569552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin.
    Du J; Wang T; Li Y; Zhou Y; Wang X; Yu X; Ren X; An Y; Wu Y; Sun W; Fan W; Zhu Q; Wang Y; Tong X
    Free Radic Biol Med; 2019 Feb; 131():356-369. PubMed ID: 30557609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response‑induced upregulation of CHAC1 expression.
    Wang Z; Li M; Liu Y; Qiao Z; Bai T; Yang L; Liu B
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34558645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.
    Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF
    Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer.
    Qiu C; Yang L; Wang B; Cui L; Li C; Zhuo Y; Zhang L; Zhang S; Zhang Q; Wang X
    Biomed Pharmacother; 2019 Jul; 115():108952. PubMed ID: 31078044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner.
    Yu R; Jin L; Li F; Fujimoto M; Wei Q; Lin Z; Ren X; Jin Q; Li H; Meng F; Jin G
    J Dermatol Sci; 2020 Sep; 99(3):193-202. PubMed ID: 32859456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells.
    Chen Y; Mi Y; Zhang X; Ma Q; Song Y; Zhang L; Wang D; Xing J; Hou B; Li H; Jin H; Du W; Zou Z
    J Exp Clin Cancer Res; 2019 Sep; 38(1):402. PubMed ID: 31519193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TUG1/MAZ/FTH1 Axis Attenuates the Antiglioma Effect of Dihydroartemisinin by Inhibiting Ferroptosis.
    Gong H; Gao M; Lin Y; Liu J; Hu Z; Liu J
    Oxid Med Cell Longev; 2022; 2022():7843863. PubMed ID: 36164395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.
    Zhu H; Klement JD; Lu C; Redd PS; Yang D; Smith AD; Poschel DB; Zou J; Liu D; Wang PG; Ostrov D; Coant N; Hannun YA; Colby AH; Grinstaff MW; Liu K
    J Immunol; 2021 Mar; 206(6):1395-1404. PubMed ID: 33547170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroartemisinin induces ferroptosis in T cell acute lymphoblastic leukemia cells by downregulating SLC7A11 and activating the ATF4‑CHOP signaling pathway.
    Tang N; Liu X; Liu Y; Wang H; Zhao Y; Wang H; Hu Z
    Oncol Lett; 2024 Jul; 28(1):337. PubMed ID: 38846431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism.
    Cui Z; Wang H; Li S; Qin T; Shi H; Ma J; Li L; Yu G; Jiang T; Li C
    J Pharmacol Sci; 2022 Jan; 148(1):73-85. PubMed ID: 34924133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroartemisinin Inhibits the Proliferation, Colony Formation and Induces Ferroptosis of Lung Cancer Cells by Inhibiting PRIM2/SLC7A11 Axis.
    Yuan B; Liao F; Shi ZZ; Ren Y; Deng XL; Yang TT; Li DY; Li RF; Pu DD; Wang YJ; Tan Y; Yang Z; Zhang YH
    Onco Targets Ther; 2020; 13():10829-10840. PubMed ID: 33149601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox Dyshomeostasis with Dual Stimuli-Activatable Dihydroartemisinin Nanoparticles to Potentiate Ferroptotic Therapy of Pancreatic Cancer.
    Wang Y; Chen F; Zhou H; Huang L; Ye J; Liu X; Sheng W; Gao W; Yu H; Wang F
    Small Methods; 2023 May; 7(5):e2200888. PubMed ID: 36446643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.
    Li C; Cui L; Yang L; Wang B; Zhuo Y; Zhang L; Wang X; Zhang Q; Zhang S
    Pancreas; 2020 Jan; 49(1):120-127. PubMed ID: 31856087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo.
    Chen H; Sun B; Pan S; Jiang H; Sun X
    Anticancer Drugs; 2009 Feb; 20(2):131-40. PubMed ID: 19209030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroartemisinin Induces Ferroptosis in HCC by Promoting the Formation of PEBP1/15-LO.
    Su Y; Zhao D; Jin C; Li Z; Sun S; Xia S; Zhang Y; Zhang Z; Zhang F; Xu X; Shao J; Zhang B; Zheng S
    Oxid Med Cell Longev; 2021; 2021():3456725. PubMed ID: 34925691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fe-MnO
    Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
    Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2/HO-1 pathway.
    Li D; Qi J; Wang J; Pan Y; Li J; Xia X; Dou H; Hou Y
    Free Radic Biol Med; 2019 Nov; 143():260-274. PubMed ID: 31419476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
    Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
    J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.